Duchenne and mdx muscle tissues lack dystrophin where it normally interacts with glycoproteins in the sarcolemma. Intracellular free calcium ([Ca2+]i) is elevated in Duchenne and mdx myotubes and is correlated with abnormally active calcium-specific leak channels in dystrophic myotubes. We fused Duchenne human and normal mouse myoblasts and identified heterokaryon myotubes by Hoechst 33342 staining to measure the degree to which dystrophin introduced by normal nuclei could incorporate throughout the myotube at the sarcolemma and restore normal calcium homeostasis. Dystrophin expression in myotubes was determined by immunofluorescence and confocal laser scanning microscopy. Dystrophin was expressed at the sarcolemma in normal mouse and heterokaryon myotubes, but not in Duchenne myotubes. In heterokaryons, extensive dystrophin localization occurred at the sarcolemma even where only Duchenne nuclei were present, indicating that dystrophin does not exhibit nuclear domains. Heterokaryon, normal mouse and Duchenne myotube [Ca2+]i was measured using fura-2 and fluorescence ratio imaging. Heterokaryon and normal mouse myotubes were found to maintain similar levels of [Ca2+] 
INTRODUCTION
Several theories attempt to explain muscle necrosis in Duchenne muscular dystrophy in view of an abnormal expression of dystrophin (see review, Rojas and Hoffman, 1991) . In one case, a lack of dystrophin in muscle tissues is thought to weaken the sarcolemma, producing repeated cycles of segmental plasma membrane tearing and repair that eventually destroy it. In this view, dystrophin maintains the mechanical-structural stability of the muscle architecture. In the second case, an absence of dystrophin in muscle fibers causes membrane glycoproteins normally associated with dystrophin to disperse and/or degrade, resulting in increased extracellular calcium permeability, leading to calciumdependent protease activation and abnormal proteolysis (Turner et al., 1991 (Turner et al., , 1993 . In this view, dystrophin is 1993 by The American Society for Cell Biology believed to have a role regulating integral membrane proteins (Ohlendieck and Campbell, 1991) . In both instances, an absence of dystrophin is responsible for muscle degeneration although its exact physiological role in muscle tissues remains unknown.
Dystrophin, the missing gene product in Duchenne muscular dystrophy (Hoffman et al., 1987) , is normally expressed on the cytoplasmic side of the muscle fiber sarcolemma Zubrzycka-Gaarn et al., 1988; Carpenter et al., 1990; Byers et al., 1991) and is also located at the plasma membrane in myotubes formed shortly after myoblast fusion Klamut et al., 1989; Huard et al., 1991) . Dystrophin is a 125-nm rod-like protein (427 kDa, MW) with four domains and shares sequence homology with several cytoskeletal proteins (Koenig et al., 1988) . It is proposed to exist as a homodimer where anti-parallel dys-trophin monomers interact by their N-terminal domain (a-actinin sequences) with cortical actin filaments and by their C-terminal domain (unique dystrophin sequences) with sarcolemmal glycoproteins (Ervasti and Campbell, 1991) . In addition to being expressed at the sarcolemma in muscle fibers, dystrophin is also found at low levels in the triadic junctions (Knudson et al., 1988; Bornemann and Schmalbruch, 1991) and at higher levels at the neuromuscular (Huard et al., 1992) and myotendinous junctions (Samitt and Bonilla, 1990; Tidball and Law, 1991) .
The idea that dystrophin serves a primarily mechanical role preventing stress at the membrane and decreasing the probability of tears is appealing in its simplicity; however, the permeability to sodium and levels of intracellular sodium were found to be the same in dystrophic and normal muscle, ruling out nonspecific membrane leaks (Turner et al., 1991) . On the other hand, total calcium (Bertorini et al., 1982; Dunn and Radda, 1991) and intracellular free calcium ([Ca21] i) concentrations (Mongini et al., 1988; Sanchez et al., 1988; Turner et al., 1988; Bakker et al., 1993) were found to be significantly elevated in muscle tissues lacking dystrophin.
[Ca2+]1 is twofold higher in isolated mdx flexor digitorum brevis (fdb) fibers (Turner et al., 1988) (Fong et al., 1990) . Patch clamp analysis has identified leak channels selective for calcium with a greater probability of opening (Po) in dystrophic myotubes. These abnormally active calcium leak channels could account for the elevated resting
[Ca21]i levels in Duchenne and mdx muscle cells (Fong et al., 1990; Turner et al., 1991) . Similarly, mdx cerebellar granule neurons possessed a calcium-specific leak channel that was more active than normal neurons (Haws and Lansman, 1991) . Furthermore, mdx neurons had significantly higher resting levels of [Ca2+]i and exhibited poor calcium control during brief periods of calcium stress (Hopf and Steinhardt, 1992) .
In support of a role for calcium in muscle fiber damage, mdx fibers with stably elevated [Ca21]i levels exhibited an enhanced rate of muscle protein degradation (Turner et al., 1988; MacLennan et al., 1991) . Therefore, a problem in [Ca2+] i homeostasis occurs in dystrophindeficient muscle and neural tissues, which may be linked to the pathophysiology of the disease. This link between the presence of dystrophin and a measurable index of normal cell physiology presents an opportunity to test whether the reintroduction of dystrophin expression can re-establish normal cell function, an important prerequisite for the success of myoblast fusion therapy (Partridge, 1991 
MATERIALS AND METHODS Muscle Cell Cultures
Satellite cell myoblasts were isolated from normal mouse (C57B1/ 10ScSn) hindlimb muscle according to the procedure described by Dimario and Strohman (1988) Tissue culture plastic will not adequately transmit light in the near ultraviolet wavelength range needed to excite fura-2. Therefore, myoblasts had to be cultured in 35-mm plastic petri dishes modified by drilling a 20-mm diameter hole through the center and permanently attaching a glass coverslip to the bottom with 100% silicone rubber aquarium sealant (Dow Corning, Midland, MI). For dystrophin immunofluorescence staining, myoblasts were cultured in four-chamber glass slide flasks (Lab-Tek, Napierville, IL) . All petri dishes and glass slides were treated with 0.01% calf skin collagen, type I (Sigma), in Puck's saline and sterilized with ultraviolet light.
Fura-2 Intracellular Calcium Measurements
Intracellular free calcium measurements using fura-2 and fluorescence ratio imaging were made in elongated myotubes, similar in size and shape, and at the same age in cell culture from 6 to 13 d of differentiation. Myotubes were loaded with 10 ,M fura-2/AM for 1 hour, in the dark, at room temperature, in Puck's saline solution with 8% dialyzed fetal bovine serum (Gemini Bioproducts, Calabasas, CA). To facilitate probe uptake into the myotube, fura-2/AM (Molecular Probes, Eugene, OR) at a 10-mM stock concentration in dimethyl sulfoxide was mixed 1:1 with 25% (wt/vol) Pluronic F-127 (Molecular Probes). Fura-2/AM is cell-permeant and readily enters the cell interior where nonspecific cytoplasmic esterases hydrolyze off the acetoxymethyl ester groups releasing fura-2, the cell impermeant form. After fura-2 loading, myotube cultures were washed three times with rodent saline solution to remove unincorporated fura-2. The rodent saline solution consisted of the following (in mM): 138 NaCl, 2.7 KCl, 1.8 CaC12, 1.06 MgCl2, 5.6 glucose, and 12.4 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH. = 7.2. The CaCl2 concentration was raised to 18 mM to stress myotubes with 10-fold higher [Ca21],.
Fura-2 ratio images were obtained using a Nikon Fluorite X40 objective (Garden City, NY; NA 1.30 oil) on a Zeiss IM-35 inverted Molecular Biology of the Cell microscope (Thornwood, NY) converted for microfluorimetry. An alternating filter wheel contained interference filters (for excitation mode ratioing) set to deliver light at 385 and 345 nm with half-band widths of 10 nm. A 395-nm dichroic mirror in the light path directed excitation and emission light to their appropriate destinations. Fura-2 fluorescence emissions occurring after passage through a 450-nm-long pass filter was quantitated using an air-cooled, Dage 66 silicon-intensified target camera (Dage-MTI, Michigan City, IN). The signal was digitized with a Gould 5000 image processor under the control of a PDP 11/ 73 microcomputer (Digital Equipment, Marlboro, MA). Myotube ratio images were obtained approximately every 3.5 s and were permanently stored on a Panasonic (Secaucus, NJ) optical laser disk during the experiment. Myotube [Ca2"J concentrations were determined from laser disk stored images using the formula described by Grynkiewicz et al. (1985) : [Ca2"Ji = Kd (R -vR min)/(vR max -R), where R max is the fura-2 ratio in saturating calcium solution, R min is the fura-2 ratio in zero calcium solution (ethylene glycol-bis((O-aminoethyl ether)-N,N,N',N'-tetraacetic acid [EGTA]-buffered), R is the fura-2 ratio from the myotube, v is 0.71 the correction factor for fura-2 fluorescence in the myotube (Fong et al., 1990) , and Kd is the fura-2 effective dissociation constant at 370C.
Heterokaryons were identified following [Ca2"I measurements by Hoechst 33342 staining. A stock concentration of Hoechst 33342 (1 mg/ml) was diluted 1/1000 with rodent saline solution and incubated with myotubes for 10 min at 23°C. Mouse nuclei have punctate chromatin staining and human nuclei appeared smooth in fluorescence when excited at 385 nm (Blau et al., 1983; Huard et al., 1991) .
The myotube [Ca2"Ji values are nanomolar and are reported as the mean ± SEM; n is the sample number. Statistical significance was determined by the Student's t test and [Ca2+]i differences where p < 0.05 were considered significant.
Immunocytochemical Detection of Dystrophin
The dystrophin polyclonal antibody was made against a chemically synthesized decapeptide representing the predicted sequences from the last 10 amino acids of the carboxy-terminal (C-terminal) portion of human dystrophin (Ervasti et al., 1990) . The dystrophin antiserum was a gift from Dr. Kevin P. Campbell (University of Iowa, Iowa City, IA). The secondary antibody was a F(ab)2' donkey anti-rabbit immunoglobulin conjugated to tetramethyl rhodamine isothiocyanate (TRITC), and normal donkey serum was obtained from Jackson Immunoresearch Laboratories (Avondale, PA).
Muscle cell cultures undergoing early stages of differentiation were probed for dystrophin expression by indirect immunofluorescence. Myotubes were washed one time with phosphate-buffered saline (PBS) and fixed with acetone:methanol (1:1) for 3 min at room temperature. Myotubes were then blocked with 5% normal donkey serum in PBS for 1 h. The donkey serum was removed, and dystrophin antibody was diluted 1:1000 with PBS, 2.5% donkey serum, and 0.05% tween-20 before being added to appropriate myotube chambers. The control myotube samples contained normal donkey serum in place of dystrophin antibody, and all myotube samples were incubated overnight (21°C). Afterwards, myotubes were exposed for 1 h to secondary antibody diluted 1:250 with PBS, 1% donkey serum, and 0.05% tween-20. All incubations occurred at 21°C, in a dark, humidified chamber, and after each treatment, myotube chambers were washed three times, over 15 min, with PBS and 0.05% tween-20. Dystrophin labeled myotubes were mounted in a glycerol:PBS (1:1) medium containing 5% n-propyl gallate (Sigma) as an antioxidant. A glass coverslip was mounted over the myotubes, and the edges were sealed with nail polish. Hoechst 33342 was used as a last step in the dystrophin immunostaining procedure to stain myotube nuclei.
Confocal myotube images were obtained with a laser scanning confocal microscope system (BioRad MRC 600, Cambridge, MA) equipped with a Nikon Fluor X40 (1.30 NA) oil-immersion objective. The green line (514 nm) of the argon ion laser was used for fluorescence excitation, and the resulting fluorescence emission occurring at .550 nm was collected. Each myotube image was scanned 10 times, averaged, and analyzed directly by the MRC 600 software to give the pixel intensity profile of dystrophin myotube staining.
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RESULTS
Dystrophin Expression
We induced cell fusion between normal mouse and Duchenne myoblasts to reintroduce normal nuclei, and therefore normal dystrophin, into dystrophic myotubes. To produce heterokaryons with equal or greater numbers of Duchenne nuclei, it was necessary to initiate Duchenne cultures at a density that was eight-times greater than mouse. Therefore, we cocultured Duchenne (105 cells/ml) and normal mouse (1.2 X 104 cells/ml) myoblasts and differentiated them by placing them in reduced serum growth medium. Myotubes were observed 2-4 d after incubation in differentiation medium, but were not used until 1 wk later to allow for a brief period of development.
Confocal laser scanning microscopy and immunofluorescence was used to probe 1.5-2 wk-old normal mouse and Duchenne myotubes, and heterokaryons for their ability to express dystrophin and to determine its location in the cell (Figures 1 and 2 ). Normal mouse myotubes and heterokaryons exhibited strong fluorescence labeling of dystrophin at the sarcolemma in confocal images. In some instances, dystrophin occurred as patches of strong accumulation at the sarcolemma while other areas were reduced for dystrophin labeling. In contrasts, Duchenne myotubes did not show any evidence of dystrophin labeling at the sarcolemma. We also observed no sarcolemmal dystrophin staining in cultures of mdx myotubes or normal mouse fibroblasts.
These results support the specificity of antibody labeling of dystrophin in normal mouse and heterokaryon myotubes.
To better determine dystrophin labeling at the myotube sarcolemma, confocal images were traversed several times-by a line that was perpendicular to the length of the myotube and fluorescence intensities of the secondary antibody were measured along the line. In Figure  1 , normal mouse myotubes generated sharp peaks at each point where the line crossed the sarcolemma indicating that dystrophin was localized there. Also, the interior of the myotube exhibited greatly reduced fluorescence compared with the sarcolemma. However, some internal myotube areas showed positive staining, possibly representing dystrophin before being transferred to its muscle surface location. In contrast, Duchenne myotubes exhibited a lack of dystrophin fluorescence staining and an absence of peaks for dystrophin at the sarcolemma. In Duchenne myotubes, the profile of dystrophin expression showed small increases as the line passed over the interior of the myotube. This profile most likely reflects nonspecific secondary antibody retention because serum-blocked controls also produced low intracellular fluorescence but no sarcolemmal staining.
Normal mouse myotubes were investigated further for dystrophin labeling in longitudinal sections using confocal laser scanning microscopy (Figure 3 ). At the apical region of the myotube, dystrophin exhibited a lattice network expression over the myotube sarcolemma. As the confocal plane was moved inward into the myotube, the presence of dystrophin labeling at the sarcolemma was clearly visible as shown by strong fluorescence at this area. Also, nuclei appeared as dark spots inside the myotube showing that the dystrophin antibody was not labeling membrane nonspecifically. At the bottom of the myotube, near the sarcolemma and glass substrate interface, dystrophin expression occurred in a repetitive banding pattern reflective of sarcomere formation. The differences in dystrophin expression at the apical and basal areas of the myotube sarcolemma may occur as a result of myotube matu-966 ration. Alternatively, it may reflect an effect of the cell culture dish surface.
Heterokaryons were recently reported to exhibit a mode of gene expression for myosin heavy chains and a membrane protein that was suggestive of nuclear domains (Pavlath et al., 1989) . Therefore, we were interested in determining whether heterokaryons produced by the fusion of normal mouse and Duchenne myoblasts also expressed dystrophin in nuclear domains. line passed over the sarcolemma. In contrast, there was no dystrophin labeling of the nuclear membranes. (C) Dystrophin staining at the sarcolemma could also be detected over a distance 300 ,m distal to the Duchenne nucleus in an area where no other nucleus was present. The end region of the elongating myotube showed strong dystrophin labeling. (D) The staining of dystrophin was strong at various locations along the length of the myotube, and in areas where staining was low, sarcolemmal dystrophin localization was still observed. The end region of the myotube in (C) shows that peaks for dystrophin are two times greater than peaks seen in areas occupied by normal nuclei. Nuclear domains for dystrophin were not observed in heterokaryons. Bar, 15 ,Am. mouse nucleus as punctate and the Duchenne nucleus as smooth in fluorescence (Blau et al., 1983) . Dystrophin labeling was detected in the area occupied by normal nuclei as shown by bright fluorescence and distinct peaks at the sarcolemma (Figure 2 ). In addition, the plasma membrane area around the isolated Duchenne nucleus was also stained for dystrophin. Furthermore, we found that dystrophin labeling at the sarcolemma extended down the length of the myotube '300 um beyond the Duchenne nucleus where no other nucleus was present. The sarcolemmal dystrophin labeling at the area most distal to the Duchenne nucleus was almost twofold greater than labeling in the area of normal nu- Vol. 4, September 1993 clei. This result shows that dystrophin expression in heterokaryons does not reflect the presence of nuclear domains and that normal sarcolemmal localization of dystrophin can occur over the entire hybrid myotube.
Calcium Regulation
Resting [Ca2+]i levels were measured in normal and dystrophin-deficient muscle cells at myoblast and myotube stages. We found no significant difference in resting [Ca2"]j levels in mouse myoblasts (104 ± 8 nM, n = 31, normal mouse vs. 109 ± 6, n = 44, mdx, p > 0.5) or in human myoblasts (133 ± 9 nM, n = 47, normal human = 18), normal human (147 ± 7 nM, n = 11), and heterokaryon (141 ± 9 nM, n = 11) myotubes all maintained lower resting levels of [Ca2+] When we compared individual myotube resting [Ca2+]i levels, a gaussian distribution of calcium ranges was found for normal mouse myotubes and heterokaryons ( Figure 6 ). In contrast, Duchenne myotubes had two peak calcium ranges. One peak occurred in the normal calcium ranges while the other peak was 160 nM higher in the calcium range (36% of sample). Furthermore, in 
DISCUSSION
These results showed that dystrophin was expressed throughout the myotube in all mouse-human heterokaryons as has been reported for heterokaryons between mdx mice and normal rat myoblasts (Huard et al., 1991) . Heterokaryons with normal mouse nuclei and Duchenne nuclei expressed dystrophin over the areas occupied by the Duchenne nuclei. In the most extreme example, the expression of dystrophin continued -300 ,um down the length of the myotube beyond the last nucleus, which was a Duchenne nucleus. (Porter et al., 1992) . We have used fura-2 responses to measure the levels of free intracellular calcium and to compare calcium regulation in normal, dystrophic, and heterokaryon myotubes. To avoid possible artifacts, it is necessary to calibrate fura-2 responses in cytoplasm in both myotube types by clamping intracellular free calcium to known levels with microinjected Ca2+/EGTA-buffered solutions (Turner et al., 1988) . This procedure gives rise to a correction factor that was the same for normal and mdx mouse fibers. Also, permeabilized myotubes in solutions at physiological levels of free intracellular calcium gave similar correction factors (Fong et al., 1990) . Recently another group has confirmed our findings of elevated [Ca21]i levels in mdx myotubes using fura-2 calibrated by saponin permeabilization in known extracellular calcium-EGTA/bis-(o-aminophenoxy)-N,N,N',N'-tetraacetic acid (BAPTA)-buffered solutions (Bakker et al., 1993) . Other free calcium indicators like quin-2 (Mongini et al., 1988) , indo-1 (Sarabia and Klip, 1989) , and calcium-selective microelectrodes (Sanchez et al., 1988) showed significantly higher levels of [Ca2+]i in dystrophin-deficient muscle cells, although absolute levels can not be compared by these different methods. There are two other independent methods which indicate higher levels in mdx fibers and myotubes. The higher level of protein degradation can be shown to be entirely correlated with the fura-2-measured free intracellular calcium manipulated independently of fiber type (Turner et al., 1988) . The kinetics of calcium resequestration can also be directly correlated with the fura-2-measured levels in myotubes (Turner et al., 1991 [Ca2+] i were at the lower normal levels in Duchenne human-normal mouse myotube heterokaryons, and this did not depend on the proportion of normal to dystrophic nuclei in the hybrid myotubes.
The defect in muscle [Ca2+] i control in mdx and Duchenne is correlated with altered calcium leak channel activity (Turner et al., 1988; 1991; Fong et al., 1990) , which results from calcium-dependent proteolysis (Turner et al., 1993) . In mdx myotubes, calcium leak channel Po is high and [Ca2"]i is significantly elevated above normal. However, 50 ,uM leupeptin can prevent the increase in calcium leak channel activity and free calcium levels in the absence of dystrophin, which suggests that dystrophin may function to shield calcium leak channels from proteolysis (Turner et al., 1993) . We hypothesize that in dystrophic muscle the absence of dystrophin increases the amount of calcium-dependent proteolysis of leak channels increasing their Po and resting [Ca2+]i and results in more proteolysis in a positive feedback system (Turner et al., 1993) . Different initial levels of myotube activity might lead to higher calcium values, which by means of this positive feedback system could give rise to a distinct population of Duchenne myotubes with elevated [Ca2+]i levels.
We have shown that heterokaryon myotubes express dystrophin, incorporate it throughout the fused myotubes at the sarcolemma, and produce resting [Ca2"] levels that are significantly lower than dystrophin-deficient Duchenne myotubes. These results are promising for the suggested use of myoblasts for cell-fusion therapy in Duchenne muscular dystrophy (Karpati et al., 1989; Morgan et al., 1990; Partridge, 1991) .
